Huynh Panitda, Fleisch Elgar, Brändle Michael, Kowatsch Tobias, Jovanova Mia
University of St Gallen, St Gallen, Switzerland.
Institute of Technology Management, University of St. Gallen, St. Gallen, Switzerland.
BMJ Open. 2024 Dec 20;14(12):e085797. doi: 10.1136/bmjopen-2024-085797.
Metabolic disorders (type 2 diabetes, insulin resistance, hyperglycaemia, obesity, hyperlipidaemia, hypertension, non-alcoholic fatty liver disease and metabolic syndrome) are leading causes of mortality and disability worldwide. These disorders disproportionately affect older adults relative to those younger. Digital health technologies (DHTs), such as patient monitoring, digital diagnostics and digital therapeutics, emerge as promising tools for health promotion in day-to-day life. However, their role in targeting metabolic disorders, particularly among a key demographic of older adults, is not yet fully understood. Thus, this study aims to scope the use of DHTs in managing metabolic health disorders among older adults. To our knowledge, this is the first review to categorise DHTs for older adults with metabolic disorders, contributing to the growing literature in the intersection of metabolic disorders and DHTs.
We will conduct a scoping review following the recommended framework by Arksey and O'Malley. Our search will focus on three primary concepts: metabolic disorders, DHTs and older adults. We plan to search five online databases (Cochrane, ScienceDirect, PubMed, Scopus and Web of Science) to identify original research articles published between January 2014 and January 2024. Two independent reviewers will screen articles based on predefined eligibility criteria, with a third reviewer resolving conflicts. Data will be extracted using a standardised form, and results will be synthesised qualitatively and quantitatively. The database searches, data collection and analysis are planned and have not been conducted.
No ethics approval is required for this protocol and scoping review. Data will be used only from published studies with appropriate ethics approval. Results will be disseminated in a peer-reviewed publication.
代谢紊乱(2型糖尿病、胰岛素抵抗、高血糖、肥胖、高脂血症、高血压、非酒精性脂肪性肝病和代谢综合征)是全球死亡和残疾的主要原因。与年轻人相比,这些疾病对老年人的影响尤为严重。数字健康技术(如患者监测、数字诊断和数字治疗)成为日常生活中促进健康的有前景的工具。然而,它们在针对代谢紊乱方面的作用,尤其是在老年这一关键人群中,尚未得到充分了解。因此,本研究旨在探讨数字健康技术在管理老年人代谢健康紊乱中的应用。据我们所知,这是第一项对患有代谢紊乱的老年人的数字健康技术进行分类的综述,为代谢紊乱与数字健康技术交叉领域不断增长的文献做出了贡献。
我们将按照阿克西和奥马利推荐的框架进行范围综述。我们的搜索将集中在三个主要概念:代谢紊乱、数字健康技术和老年人。我们计划搜索五个在线数据库(Cochrane、ScienceDirect、PubMed、Scopus和Web of Science),以确定2014年1月至2024年1月期间发表的原创研究文章。两名独立评审员将根据预定义的纳入标准筛选文章,第三名评审员解决冲突。数据将使用标准化表格提取,结果将进行定性和定量综合分析。数据库搜索、数据收集和分析计划已制定,但尚未进行。
本方案和范围综述无需伦理批准。仅使用具有适当伦理批准的已发表研究中的数据。结果将在同行评审的出版物中传播。